IMPACT OF MARROW COMPLETE RESPONSE IN THE NATURAL HISTORY OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) TREATED WITH HYPOMETHYLATING AGENTS

被引：0
|
作者：
Pierola, A. Alfonso [1 ]
Montalban-Bravo, G. [1 ]
Takahashi, K. [1 ]
Jabbour, E. J. [1 ]
Kadia, T. [1 ]
Ravandi, F. [1 ]
Cortes, J. [1 ]
DiNardo, C. [1 ]
Daver, N. [1 ]
Borthakur, G. [1 ]
Pemmaraju, N. [1 ]
Konopleva, M. [1 ]
Bueso-Ramos, C. [2 ]
Pierce, S. [1 ]
Kantarjian, H. [1 ]
Garcia-Manero, G. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Hematopathol, Houston, TX 77030 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P665
引用
收藏
页码：263 / 264
页数：2
相关论文
共 50 条
  • [1] Outcomes of Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents
    Venugopal, Sangeetha
    Chien, Kelly S.
    Hammond, Danielle
    Kanagal-Shamanna, Rashmi
    Sasaki, Koji
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Konopleva, Marina
    Daver, Naval
    Ravandi, Farhad
    Pemmaraju, Naveen
    Short, Nicholas J.
    Issa, Ghayas C.
    Takahashi, Koichi
    Estrov, Zeev E.
    Pierce, Sherry A.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    BLOOD, 2021, 138
  • [2] Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Wei, Yue
    Zheng, Hong
    Lockyer, Pamela
    Bao, Naran
    Darbaniyan, Faezeh
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Soltysiak, Kelly A.
    Yang, Hui
    Ganan-Gomez, Irene
    Do, Kim-Anh
    Colla, Simona
    Chien, Kelly S.
    Montalban-Bravo, Guillermo
    Daver, Naval
    Garcia-Manero, Guillermo
    BLOOD, 2021, 138 : 3664 - +
  • [3] Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents
    Alfonso, Ana
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Jabbour, Elias J.
    Kadia, Tapan
    Ravandi, Farhad
    Cortes, Jorge
    Estrov, Zeev
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina
    Bueso-Ramos, Carlos
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (07) : 599 - 606
  • [4] IMPACT OF THE MUTATIONAL PROFILE AT THE TIME OF DIAGNOSIS IN RESPONSE OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA TREATED WITH HYPOMETHYLATING AGENTS
    Montalban-Bravo, G.
    Alfonso, A.
    Patel, K.
    Jabbour, E.
    Benton, C.
    Kadia, T.
    Ravandi, F.
    Cortes, J.
    DiNardo, C.
    Daver, N.
    Borthakur, G.
    Pemmaraju, N.
    Konopleva, M.
    Ganan-Gomez, I.
    Nogueras-Gonzalez, G.
    Huang, X.
    Wang, F.
    Xingzhi, S.
    Bueso-Ramos, C.
    Futreal, A.
    Kantarjian, H.
    Takahashi, K.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 184 - 184
  • [5] FLT3 mutations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)
    Bhamidipati, Pavan Kumar
    Daver, Naval Guastad
    Kantarjian, Hagop
    Pierce, Sherry
    Daver, Roshni
    Cortes, Jorge E.
    Ravandi, Farhad
    Mathisen, Michael
    Pemmaraju, Naveen
    Nazha, Aziz
    Kadia, Tapan M.
    Jabbour, Elias
    Borthakur, Gautam
    Faderl, Stefan
    Garcia-Manero, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] IMPACT OF BONE MARROW FIBROSIS IN RESPONSE TO AZACITIDINE IN 94 PATIENTS WITH MYELODISPLASTIC SYNDROMES (MDS), CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ACUTE MYELOID LEUKEMIA
    Reda, G.
    Riva, M.
    Cassin, R.
    Fattizzo, B.
    Deodato, M.
    Freyrie, A.
    Molteni, A.
    Cairoli, R.
    Cortelezzi, A.
    HAEMATOLOGICA, 2016, 101 : 241 - 242
  • [7] Impact Of The Achievement Of a Complete Cytogenetic Response (CCyR) On Outcome In Patients (pts) With Myelodysplastic Syndromes (MDS) Treated With Hypomethylating Agents (HMA)
    Jabbour, Elias
    Kantarjian, Hagop M.
    Qiao, Wei
    Strati, Paolo
    Khan, Navira F.
    Cortes, Jorge E.
    Hoehn, Daniela
    Hu, Jianhua
    Obrien, Susan
    Bryan, Jeffrey
    Prescott, Hillary
    DiNardo, Courtney D.
    Daver, Naval
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    BLOOD, 2013, 122 (21)
  • [8] Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents
    Jabbour, Elias
    Strati, Paolo
    Cabrero, Monica
    O'Brien, Susan
    Ravandi, Farhad
    Bueso-Ramos, Carlos
    Wei, Qiao
    Hu, Jianhua
    Abi Aad, Simon
    Short, Nicholas J.
    Dinardo, Courtney
    Daver, Naval
    Kadia, Tapan
    Wierda, William
    Wei, Yue
    Colla, Simona
    Borthakur, Gautam
    Cortes, Jorge
    Estrov, Zeev
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 351 - 358
  • [9] Incidence of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in Norway 1993-2006
    Schoonen, W.
    Aagnes, B.
    Bray, F.
    Hansen, S.
    Fryzek, J.
    Weiderpass, E.
    LEUKEMIA RESEARCH, 2009, 33 : S64 - S64
  • [10] Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    CANCERS, 2021, 13 (07)
12345